Literature DB >> 16216154

The marijuana withdrawal syndrome: diagnosis and treatment.

Margaret Haney1.   

Abstract

A subset of marijuana smokers develop a cannabis use disorder and seek treatment for their marijuana use on their own initiative. A less well-known consequence of daily, repeated marijuana use is a withdrawal syndrome, characterized by a time-dependent constellation of symptoms: irritability, anxiety, marijuana craving, decreased quality and quantity of sleep, and decreased food intake. Treatment studies show that rates of continuous abstinence are low (comparable to relapse rates for other abused drugs), and more treatment options are needed. The objective of this review is to update clinicians on the current state of marijuana research and to describe features of marijuana withdrawal to facilitate the diagnosis and treatment of cannabis use disorders.

Entities:  

Mesh:

Year:  2005        PMID: 16216154     DOI: 10.1007/s11920-005-0036-1

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  44 in total

Review 1.  Epidemiology of substance use in adolescence: prevalence, trends and policy implications.

Authors:  A Bauman; P Phongsavan
Journal:  Drug Alcohol Depend       Date:  1999-07-01       Impact factor: 4.492

2.  Relapse in outpatient treatment for marijuana dependence.

Authors:  Brent A Moore; Alan J Budney
Journal:  J Subst Abuse Treat       Date:  2003-09

3.  Brief treatments for cannabis dependence: findings from a randomized multisite trial.

Authors: 
Journal:  J Consult Clin Psychol       Date:  2004-06

4.  Sodium valproate in benzodiazepine withdrawal.

Authors:  S Apelt; H M Emrich
Journal:  Am J Psychiatry       Date:  1990-07       Impact factor: 18.112

5.  Adults seeking treatment for marijuana dependence: a comparison with cocaine-dependent treatment seekers.

Authors:  A J Budney; K J Radonovich; S T Higgins; C J Wong
Journal:  Exp Clin Psychopharmacol       Date:  1998-11       Impact factor: 3.157

6.  Marijuana withdrawal among adults seeking treatment for marijuana dependence.

Authors:  A J Budney; P L Novy; J R Hughes
Journal:  Addiction       Date:  1999-09       Impact factor: 6.526

7.  The use of divalproex in alcohol relapse prevention: a pilot study.

Authors:  Kathleen T Brady; Hugh Myrick; Scott Henderson; Scott F Coffey
Journal:  Drug Alcohol Depend       Date:  2002-08-01       Impact factor: 4.492

8.  Psychiatric symptoms in male cannabis users not using other illicit drugs.

Authors:  A Troisi; A Pasini; M Saracco; G Spalletta
Journal:  Addiction       Date:  1998-04       Impact factor: 6.526

9.  The time course and significance of cannabis withdrawal.

Authors:  Alan J Budney; Brent A Moore; Ryan G Vandrey; John R Hughes
Journal:  J Abnorm Psychol       Date:  2003-08

10.  Preference for high- versus low-potency marijuana.

Authors:  L D Chait; K A Burke
Journal:  Pharmacol Biochem Behav       Date:  1994-11       Impact factor: 3.533

View more
  45 in total

1.  Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity.

Authors:  Lisa K Brents; Anna Gallus-Zawada; Anna Radominska-Pandya; Tamara Vasiljevik; Thomas E Prisinzano; William E Fantegrossi; Jeffery H Moran; Paul L Prather
Journal:  Biochem Pharmacol       Date:  2012-01-18       Impact factor: 5.858

2.  Abnormal medial prefrontal cortex activity in heavy cannabis users during conscious emotional evaluation.

Authors:  Michael J Wesley; Joshua A Lile; Colleen A Hanlon; Linda J Porrino
Journal:  Psychopharmacology (Berl)       Date:  2015-12-22       Impact factor: 4.530

3.  Magnitude and duration of cue-induced craving for marijuana in volunteers with cannabis use disorder.

Authors:  Leslie H Lundahl; Mark K Greenwald
Journal:  Drug Alcohol Depend       Date:  2016-07-18       Impact factor: 4.492

4.  Personality disorders and the 3-year course of alcohol, drug, and nicotine use disorders.

Authors:  Deborah Hasin; Miriam C Fenton; Andrew Skodol; Robert Krueger; Katherine Keyes; Timothy Geier; Eliana Greenstein; Carlos Blanco; Bridget Grant
Journal:  Arch Gen Psychiatry       Date:  2011-11

Review 5.  "Herbal incense": designer drug blends as cannabimimetics and their assessment by drug discrimination and other in vivo bioassays.

Authors:  Torbjörn U C Järbe; Roger S Gifford
Journal:  Life Sci       Date:  2013-07-25       Impact factor: 5.037

Review 6.  Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity?

Authors:  William E Fantegrossi; Jeffery H Moran; Anna Radominska-Pandya; Paul L Prather
Journal:  Life Sci       Date:  2013-09-29       Impact factor: 5.037

7.  Smoked marijuana attenuates performance and mood disruptions during simulated night shift work.

Authors:  Diana R Keith; Erik W Gunderson; Margaret Haney; Richard W Foltin; Carl L Hart
Journal:  Drug Alcohol Depend       Date:  2017-06-28       Impact factor: 4.492

Review 8.  Self-administration of cocaine, cannabis and heroin in the human laboratory: benefits and pitfalls.

Authors:  Margaret Haney
Journal:  Addict Biol       Date:  2008-10-09       Impact factor: 4.280

9.  Does Cannabis Cause, Exacerbate or Ameliorate Psychiatric Disorders? An Oversimplified Debate Discussed.

Authors:  Margaret Haney; A Eden Evins
Journal:  Neuropsychopharmacology       Date:  2015-08-19       Impact factor: 7.853

10.  Cognitive behavioral therapy and the nicotine transdermal patch for dual nicotine and cannabis dependence: a pilot study.

Authors:  Kevin P Hill; Lindsay H Toto; Scott E Lukas; Roger D Weiss; George H Trksak; John M Rodolico; Shelly F Greenfield
Journal:  Am J Addict       Date:  2013 May-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.